| Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
|---|
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP1334099B1 Herbicidally active pyridine sulfonyl urea derivatives |
| 03/10/2004 | CN1481368A Gyrase imhibitors and uses thereof |
| 03/09/2004 | US6703506 Amino acid ester containing azole antifungals |
| 03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/04/2004 | WO2004018486A1 Azole derivatives as antifungal agents |
| 03/04/2004 | WO2004018485A1 Azole derivatives as antifungal agents |
| 03/04/2004 | WO2004018455A1 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 03/04/2004 | US20040044204 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents |
| 03/04/2004 | US20040044203 Anticancer agents |
| 03/04/2004 | US20040044081 Hypotensive agents; cardiovascular disorders; anticholesterol agents; antiarrhythmia agents |
| 03/04/2004 | US20040044057 5- substituted tetralones as inhibitors of ras farnesyl trransferase |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044042 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040044009 Drug abuse; cental nervous system disorders; cognition activators |
| 03/04/2004 | US20040044000 Cardiovascular disorders; antiarthritic agents; inflammatory bowel disorders; vision defects; respiratory system disorders |
| 03/04/2004 | US20040043989 Therapy for drug resistant bacteria; topoisomerase inhibitor |
| 03/04/2004 | US20040043986 Cardiovascular disorders; inflammatory bowel disorders; antiarthritic agents; skin disorders; vision defects; osteoporosis |
| 03/04/2004 | US20040043983 Cardiovascular disorders; antiarthritic agents; inflammatory bowel disorders; vision defects; respiratory system disorders |
| 03/04/2004 | US20040043979 Antiarthritic agents; cardiovascular disorders; imflammatory bowel disorders; skin disordfers; vision disorders |
| 03/04/2004 | CA2496246A1 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 03/03/2004 | EP1394175A1 Inhibitors of interleukin-1beta converting enzyme |
| 03/03/2004 | EP1394162A1 Intermediates of azole antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1394151A1 Preventives/ remedies for complications of diabetes |
| 03/03/2004 | EP1394142A1 Carboxylic acid intermediates of antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1392684A1 Thiazole compounds useful as inhibitors of protein kinases |
| 03/03/2004 | EP1392676A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 03/03/2004 | EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
| 03/03/2004 | EP0932602B1 Bases of cationic oxidation, their use for oxidative dyeing of keratin fibres, dye compositions and dyeing processes |
| 03/03/2004 | EP0906313B1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 03/03/2004 | CN1478778A 抗真菌剂及其制备方法和中间体 Antifungal agent and its preparation method and intermediates |
| 03/03/2004 | CN1140513C Phenylsulphenyl ureas, process for their preparation and their use as herbicides and plant-growth regulators |
| 03/02/2004 | US6699994 Biaryl compounds as serine protease inhibitors |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 02/26/2004 | WO2003086271A3 Azole derivatives as antifungal agents |
| 02/26/2004 | WO2003062388A3 Inhibition of rna function |
| 02/26/2004 | WO2003050261A3 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
| 02/26/2004 | WO2002098424B1 Novel anti-infectives |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/26/2004 | US20040039033 Administering (1-phenyl-2-heteroaryl)ethyl-guanidine compounds for treating ischemic conditions including myocardial infarction, congestive heart failure, and cardiac arrhythmias |
| 02/26/2004 | US20040039029 Thiazolyl urea compounds and methods of uses |
| 02/26/2004 | US20040038991 Imidazolyl-cyclic acetals |
| 02/26/2004 | US20040038973 Treating osteoarthritis or rheumatoid arthritis |
| 02/26/2004 | US20040038959 Treating osteoarthritis or rheumatoid arthritis |
| 02/25/2004 | EP1391457A1 Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1390353A1 Triazole-derived kinase inhibitors and uses thereof |
| 02/25/2004 | EP1390350A1 Novel compounds |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/24/2004 | US6696473 Heterocyclic modulators of nuclear receptors |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/19/2004 | WO2004014892A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014885A1 Amino benzothiazole compounds with nos inhibitory activity |
| 02/19/2004 | WO2004014877A1 Process for preparing rizatriptan |
| 02/19/2004 | WO2004014870A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes |
| 02/19/2004 | WO2004014869A2 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014867A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014865A1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 02/19/2004 | WO2004014381A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014379A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014378A1 3-isoquinolinone derivatives as matrix metalloproteinase inhiitors |
| 02/19/2004 | WO2004014377A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014366A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014365A1 Phthalimide derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2003060078A9 Heterocyclic modulators of nuclear receptors |
| 02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
| 02/19/2004 | US20040033892 Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof |
| 02/19/2004 | CA2495285A1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 02/19/2004 | CA2494824A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes |
| 02/19/2004 | CA2494048A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2494014A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2492019A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/18/2004 | EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 02/18/2004 | EP0974589B1 Benzimidazole derivatives and pharmaceutically acceptable salts thereof |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1476447A Aminothiazoles and their use as adenosine receptor antagonists |
| 02/18/2004 | CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/18/2004 | CN1138765C Oxazolidinone antibacterial agents having thiocarbonyl functionality |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/12/2004 | WO2004013135A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors |
| 02/12/2004 | US20040030137 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 02/12/2004 | US20040029940 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 02/12/2004 | US20040029898 Anticancer agents |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029720 Supported group 8-10 transition metal olefin polymerization catalysts |
| 02/12/2004 | US20040026666 Imidazolium salts and their use of these ionic liquids as a solvent |
| 02/11/2004 | EP1387841A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 02/11/2004 | EP1387837A1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP0797567B1 Novel amino acid derivatives with improved multi-drug resistance activity |